InDex Pharmaceuticals
InDex Pharmaceuticals is a biopharmaceutical company developing DIMS drugs to treat inflammatory diseases and cancer.
Total raised
€26M
€26,250,000
Funding rounds
2
Investors
0
distinct backers
Active since
2010-12
latest 2014-01
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood13
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood13
base rate 12% (2+ rounds)
- ▲ 19y since founding
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2014-02-01 | Other | €18M | — | View deal → |
| 2011-01-01 | Other | €8.3M | — | View deal → |